Abiopharma

Director Bernstein Bruce 🟢 acquired 500.0K shares of XWELL, Inc. (XWEL) Transaction Date: Aug 25, 2026 | Filing ID: 104860

Director Lebowitz Michael 🟢 acquired 50.0K shares of XWELL, Inc. (XWEL) Transaction Date: Aug 25, 2026 | Filing ID: 104859

📋 Kurtz Ronald M MD (Officer) plans to sell 5K shares of RxSight, Inc. (at $6.96 each, total $35K) Filed: Sep 02, 2026 | ID: 000002

📋 Wilterding Mark (Officer) plans to sell 8K shares of RxSight, Inc. (at $6.96 each, total $54K) Filed: Sep 02, 2026 | ID: 000002

📋 Goldshleger Ilya (Officer) plans to sell 2K shares of RxSight, Inc. (at $6.96 each, total $14K) Filed: Sep 02, 2026 | ID: 000002

📋 Weinberg Eric (Officer) plans to sell 2K shares of RxSight, Inc. (at $6.96 each, total $14K) Filed: Sep 02, 2026 | ID: 000002

Kurtz Ronald M MD 🟡 adjusted position in 5.1K shares (1 derivative) of RxSight, Inc. (RXST) at $6.96 Transaction Date: Aug 31, 2026 | Filing ID: 380714

Wilterding Mark 🟡 adjusted position in 7.8K shares (1 derivative) of RxSight, Inc. (RXST) at $6.96 Transaction Date: Aug 31, 2026 | Filing ID: 380713

Goldshleger Ilya 🟡 adjusted position in 2.0K shares (1 derivative) of RxSight, Inc. (RXST) at $6.96 Transaction Date: Aug 31, 2026 | Filing ID: 380711

Weinberg Eric 🟡 adjusted position in 2.0K shares (1 derivative) of RxSight, Inc. (RXST) at $6.96 Transaction Date: Aug 31, 2026 | Filing ID: 380710